drug
idarucizumab
Marketedupdated 5mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying idarucizumab
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that